DPW
RYTM icon

DiNuzzo Private Wealth’s Rhythm Pharmaceuticals RYTM Stock Holding History

DiNuzzo Private Wealth’s Portfolio RYTM Stock Details RYTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$112 Sell
1
-2
-67% -$181 ﹤0.01% 1289
2026
Q1 		$261 Hold
3
– – ﹤0.01% 1205
2025
Q4 		$322 Buy
+3
New +$318 ﹤0.01% 1184

Other funds holding RYTM

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

DiNuzzo Private Wealth's RYTM Position: Q2 2026 in Review

DiNuzzo Private Wealth reduced its Rhythm Pharmaceuticals (RYTM) stake by 67% in Q2 2026, selling an estimated $181 and leaving 1 share worth $112. The position accounts for ﹤0.01% of the portfolio, ranked #1289.

DiNuzzo Private Wealth first reported a position in RYTM in Q4 2025 and has held it in 3 quarters since. The position peaked at $322 in Q4 2025. 303 funds tracked by Wall St. Rank hold RYTM as of Q2 2026.

  • DiNuzzo Private Wealth held 1 share of Rhythm Pharmaceuticals worth $112 as of Q2 2026.
  • DiNuzzo Private Wealth sold 2 Rhythm Pharmaceuticals shares in Q2 2026, an estimated $181.
  • Rhythm Pharmaceuticals made up ﹤0.01% of DiNuzzo Private Wealth's portfolio in Q2 2026, its #1289 holding.
  • DiNuzzo Private Wealth first reported a position in Rhythm Pharmaceuticals in Q4 2025 and has held it in 3 quarters since.
  • DiNuzzo Private Wealth's Rhythm Pharmaceuticals position peaked at $322 in Q4 2025.
  • 303 funds tracked by Wall St. Rank held Rhythm Pharmaceuticals as of Q2 2026.

Based on DiNuzzo Private Wealth's 13F filing for Q2 2026, filed 10 Jul 2026.